← Back to Search

Spanish-Language Hearing Loss Toolkit for Hearing Loss

N/A
Recruiting
Led By Victoria Sanchez, Au.D., Ph.D.
Research Sponsored by University of South Florida
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up assessed 4-6 weeks post baseline assessment
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing whether Spanish-language hearing education materials help adults better understand their hearing loss and how to manage it.

Who is the study for?
This trial is for Spanish-speaking adults over 50 who identify as Hispanic/Latino, have significant hearing loss or difficulty hearing. To join, they must experience more than a mild level of hearing loss across various pitches or report substantial hearing challenges.
What is being tested?
The study is testing educational materials in Spanish designed to help participants understand and manage their hearing loss better. It compares the effectiveness of a new toolkit against existing ASHA audiology handouts.
What are the potential side effects?
Since this trial involves educational materials rather than medical treatments, there are no direct physical side effects expected from participating in this study.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~assessed 4-6 weeks post baseline assessment
This trial's timeline: 3 weeks for screening, Varies for treatment, and assessed 4-6 weeks post baseline assessment for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Self-Efficacy for Chronic Health Condition Management (generic )
Hearing impairment
Secondary study objectives
Hearing Loss Knowledge, Attitudes, and Behaviors

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Experimental GroupExperimental Treatment1 Intervention
This group will receive the Spanish-Language Hearing Loss Toolkit materials.
Group II: Active Control GroupActive Control1 Intervention
This group will receive standard of care Spanish language information from the American Speech-Language-Hearing Association (ASHA) Audiology Series

Find a Location

Who is running the clinical trial?

University of South FloridaLead Sponsor
425 Previous Clinical Trials
190,365 Total Patients Enrolled
8 Trials studying Hearing Loss
1,613 Patients Enrolled for Hearing Loss
National Institute on Deafness and Other Communication Disorders (NIDCD)NIH
352 Previous Clinical Trials
181,079 Total Patients Enrolled
59 Trials studying Hearing Loss
21,100 Patients Enrolled for Hearing Loss
Victoria Sanchez, Au.D., Ph.D.Principal InvestigatorUniversity of South Florida

Media Library

Spanish-Language Hearing Loss Toolkit for Self-Management Clinical Trial Eligibility Overview. Trial Name: NCT04534387 — N/A
Hearing Loss Research Study Groups: Active Control Group, Experimental Group
Hearing Loss Clinical Trial 2023: Spanish-Language Hearing Loss Toolkit for Self-Management Highlights & Side Effects. Trial Name: NCT04534387 — N/A
Spanish-Language Hearing Loss Toolkit for Self-Management 2023 Treatment Timeline for Medical Study. Trial Name: NCT04534387 — N/A
~24 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top